Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Feb 4, 2021
| Dan Leonard
While We Await the Vaccine, We Can Trust in Generic Drugs
Blog
Jan 29, 2021
| Kristin Murphy
AAM’s Recommendations to #SecureOurMeds
Press Release
Jan 21, 2021
| Rachel Schwartz
AAM Statement on Biden’s Executive Orders to Strengthen America’s COVID Response
Press Release
Jan 15, 2021
| Rachel Schwartz
AAM and Biosimilars Council Statement on CMS Decision to Update Part D Program
Blog
Jan 6, 2021
| Dan Leonard
2021 Generics and Biosimilars Outlook
Blog
Jan 4, 2021
| Bob Billings
Thank you, Jean Hoffman
Video
Dec 17, 2020
| Erica Klinger
Helen's Story — Savings from Biosimilar Medicines
Blog
Dec 17, 2020
| Erica Klinger
Helen Knows She Can Rely on Biosimilars
Blog
Dec 17, 2020
| Erica Klinger
GRx+Biosims Recap: A Virtual Success
Press Release
Dec 10, 2020
| Rachel Schwartz
AAM Statement on President-elect Biden Naming Katherine Tai as U.S. Trade Representative
Press Release
Dec 7, 2020
| Rachel Schwartz
AAM Statement on President-elect Biden Naming Xavier Becerra as Secretary of Health and Human Services
Blog
Dec 4, 2020
| Jewel Smith
Member Spotlight: Associate Member CMMB’s Global Health Mission
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action